Filing Details
- Accession Number:
- 0001437749-21-005202
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2021-03-05 20:01:11
- Reporting Period:
- 2021-02-12
- Accepted Time:
- 2021-03-05 20:01:11
- Original Submission Date:
- 2021-02-16
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
834365 | Biolife Solutions Inc | BLFS | Electromedical & Electrotherapeutic Apparatus (3845) | 943076866 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1812702 | Marcus Schulz | C/O Biolife Solutions, Inc. 3303 Monte Villa Parkway, Suite 310 Bothell WA 98021 | Chief Revenue Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-02-12 | 2,000 | $41.01 | 37,107 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- This Form 4/A is being filed to amend the Form 4 originally filed by the reporting person on February 16, 2021 solely to correct the transaction date in Column 2 on Table I. No other changes have been made to the original Form 4.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person effective as of November 12, 2020.